Esperion Therapeutics (ESPR) specializes in cholesterol lowering medications. President and CEO Sheldon Koenig joins Nicole Petallides to give an overview of the company. He talks about the FDA approved label expansion. Tune in to find out more about the stock market today.
Trading 360
01 Apr 2024
SHARE
The Watch List
20 Mar 2024
Futures
13 Feb 2024
Morning Trade Live
05 Mar 2024